3.26.1 html 130 168 1 false 44 0 false 6 false false R1.htm 0000001 - Document - Cover Sheet http://www.vallon-pharma.com/role/Cover Cover Cover 1 false false R2.htm 9952151 - Statement - Consolidated Balance Sheets Sheet http://www.vallon-pharma.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 9952152 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.vallon-pharma.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 9952153 - Statement - Consolidated Statements of Operations Sheet http://www.vallon-pharma.com/role/ConsolidatedStatementsofOperations Consolidated Statements of Operations Statements 4 false false R5.htm 9952154 - Statement - Consolidated Statements of Changes in Stockholders’ Equity Sheet http://www.vallon-pharma.com/role/ConsolidatedStatementsofChangesinStockholdersEquity Consolidated Statements of Changes in Stockholders’ Equity Statements 5 false false R6.htm 9952155 - Statement - Consolidated Statements of Cash Flows Sheet http://www.vallon-pharma.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 9952156 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS Sheet http://www.vallon-pharma.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESS ORGANIZATION AND DESCRIPTION OF BUSINESS Notes 7 false false R8.htm 9952157 - Disclosure - LIQUIDITY Sheet http://www.vallon-pharma.com/role/LIQUIDITY LIQUIDITY Notes 8 false false R9.htm 9952158 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.vallon-pharma.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 9952159 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://www.vallon-pharma.com/role/PROPERTYANDEQUIPMENT PROPERTY AND EQUIPMENT Notes 10 false false R11.htm 9952160 - Disclosure - ACCRUED EXPENSES Sheet http://www.vallon-pharma.com/role/ACCRUEDEXPENSES ACCRUED EXPENSES Notes 11 false false R12.htm 9952161 - Disclosure - STOCKHOLDERS’ EQUITY Sheet http://www.vallon-pharma.com/role/STOCKHOLDERSEQUITY STOCKHOLDERS’ EQUITY Notes 12 false false R13.htm 9952162 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.vallon-pharma.com/role/STOCKBASEDCOMPENSATION STOCK-BASED COMPENSATION Notes 13 false false R14.htm 9952163 - Disclosure - SEGMENT REPORTING Sheet http://www.vallon-pharma.com/role/SEGMENTREPORTING SEGMENT REPORTING Notes 14 false false R15.htm 9952164 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.vallon-pharma.com/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 15 false false R16.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 16 false false R17.htm 9955511 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.vallon-pharma.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 17 false false R18.htm 9955512 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.vallon-pharma.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.vallon-pharma.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES 18 false false R19.htm 9955513 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://www.vallon-pharma.com/role/PROPERTYANDEQUIPMENTTables PROPERTY AND EQUIPMENT (Tables) Tables http://www.vallon-pharma.com/role/PROPERTYANDEQUIPMENT 19 false false R20.htm 9955514 - Disclosure - ACCRUED EXPENSES (Tables) Sheet http://www.vallon-pharma.com/role/ACCRUEDEXPENSESTables ACCRUED EXPENSES (Tables) Tables http://www.vallon-pharma.com/role/ACCRUEDEXPENSES 20 false false R21.htm 9955515 - Disclosure - STOCKHOLDERS’ EQUITY (Tables) Sheet http://www.vallon-pharma.com/role/STOCKHOLDERSEQUITYTables STOCKHOLDERS’ EQUITY (Tables) Tables http://www.vallon-pharma.com/role/STOCKHOLDERSEQUITY 21 false false R22.htm 9955516 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://www.vallon-pharma.com/role/STOCKBASEDCOMPENSATIONTables STOCK-BASED COMPENSATION (Tables) Tables http://www.vallon-pharma.com/role/STOCKBASEDCOMPENSATION 22 false false R23.htm 9955517 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details) Sheet http://www.vallon-pharma.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails ORGANIZATION AND DESCRIPTION OF BUSINESS (Details) Details http://www.vallon-pharma.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESS 23 false false R24.htm 9955518 - Disclosure - LIQUIDITY (Details) Sheet http://www.vallon-pharma.com/role/LIQUIDITYDetails LIQUIDITY (Details) Details http://www.vallon-pharma.com/role/LIQUIDITY 24 false false R25.htm 9955519 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Diluted Net Loss Per Common Share (Details) Sheet http://www.vallon-pharma.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofDilutedNetLossPerCommonShareDetails BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Diluted Net Loss Per Common Share (Details) Details 25 false false R26.htm 9955520 - Disclosure - PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details) Sheet http://www.vallon-pharma.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details) Details 26 false false R27.htm 9955521 - Disclosure - PROPERTY AND EQUIPMENT - Narrative (Details) Sheet http://www.vallon-pharma.com/role/PROPERTYANDEQUIPMENTNarrativeDetails PROPERTY AND EQUIPMENT - Narrative (Details) Details 27 false false R28.htm 9955522 - Disclosure - ACCRUED EXPENSES (Details) Sheet http://www.vallon-pharma.com/role/ACCRUEDEXPENSESDetails ACCRUED EXPENSES (Details) Details http://www.vallon-pharma.com/role/ACCRUEDEXPENSESTables 28 false false R29.htm 9955523 - Disclosure - STOCKHOLDERS’ EQUITY - Narrative (Details) Sheet http://www.vallon-pharma.com/role/STOCKHOLDERSEQUITYNarrativeDetails STOCKHOLDERS’ EQUITY - Narrative (Details) Details 29 false false R30.htm 9955524 - Disclosure - STOCKHOLDERS’ EQUITY - Schedule of Estimate of the Fair Value of the Warrants and Assumptions (Details) Sheet http://www.vallon-pharma.com/role/STOCKHOLDERSEQUITYScheduleofEstimateoftheFairValueoftheWarrantsandAssumptionsDetails STOCKHOLDERS’ EQUITY - Schedule of Estimate of the Fair Value of the Warrants and Assumptions (Details) Details 30 false false R31.htm 9955525 - Disclosure - STOCKHOLDERS’ EQUITY - Schedule of Warrants Outstanding to Purchase Common Stock (Details) Sheet http://www.vallon-pharma.com/role/STOCKHOLDERSEQUITYScheduleofWarrantsOutstandingtoPurchaseCommonStockDetails STOCKHOLDERS’ EQUITY - Schedule of Warrants Outstanding to Purchase Common Stock (Details) Details 31 false false R32.htm 9955526 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details) Sheet http://www.vallon-pharma.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails STOCK-BASED COMPENSATION - Narrative (Details) Details 32 false false R33.htm 9955527 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock-based Compensation Expense (Details) Sheet http://www.vallon-pharma.com/role/STOCKBASEDCOMPENSATIONScheduleofStockbasedCompensationExpenseDetails STOCK-BASED COMPENSATION - Schedule of Stock-based Compensation Expense (Details) Details 33 false false R34.htm 9955528 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Activity of Stock Options (Details) Sheet http://www.vallon-pharma.com/role/STOCKBASEDCOMPENSATIONScheduleofActivityofStockOptionsDetails STOCK-BASED COMPENSATION - Schedule of Activity of Stock Options (Details) Details 34 false false R35.htm 9955529 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Assumptions Used to Estimate Fair Value of Options (Details) Sheet http://www.vallon-pharma.com/role/STOCKBASEDCOMPENSATIONScheduleofAssumptionsUsedtoEstimateFairValueofOptionsDetails STOCK-BASED COMPENSATION - Schedule of Assumptions Used to Estimate Fair Value of Options (Details) Details 35 false false R36.htm 9955530 - Disclosure - SEGMENT REPORTING (Details) Sheet http://www.vallon-pharma.com/role/SEGMENTREPORTINGDetails SEGMENT REPORTING (Details) Details http://www.vallon-pharma.com/role/SEGMENTREPORTING 36 false false All Reports Book All Reports ck0001824293-20260630.htm ck0001824293-20260630.xsd ck0001824293-20260630_cal.xml ck0001824293-20260630_def.xml ck0001824293-20260630_lab.xml ck0001824293-20260630_pre.xml ck0001824293-20260630_g1.jpg http://fasb.org/us-gaap/2026 http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/ecd/2026 true true